文献速递肿瘤 PET/CT放射性药物与辐射防护

PET血管活性评分(PETVAS)对大动脉炎患者炎症活动性定性与定量评估的性能

Performance of the PET vascular activity score (PETVAS) for qualitative and quantitative assessment of inflammatory activity in Takayasu's arteritis patients.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2020-06-22

该研究分析了54例大动脉炎(TAK)患者的64次PET/CT扫描,以医师整体评估定性、ITAS-2010定量炎症活动性,比较PETVAS与SUVmax、炎症生物标志物(CRP、ESR、PTX-3)及ITAS-2010的性能。结果显示PETVAS与PTX-3的ROC曲线下面积及Youden指数高于SUVmax、CRP、ESR和ITAS-2010,且与ITAS-2010的Spearman相关系数更高;随访中PETVAS与PTX-3的变化趋势与临床进展/缓解评估的相关性更紧密。

要点

  • 活动期TAK患者的CRP、ESR、PTX-3、SUVmax、PETVAS及ITAS-2010均显著高于非活动期患者。
  • PETVAS与PTX-3的ROC曲线下面积和Youden指数高于SUVmax、CRP、ESR及ITAS-2010。
  • PETVAS与PTX-3同ITAS-2010的Spearman相关系数高于其他指标,随访变化趋势与临床进展/缓解评估相关性更紧密。

核心结论

  • 在TAK评估中,PETVAS在定性与定量评估方面优于区域性SUVmax。
  • 与CRP和ESR相比,炎症生物标志物PTX-3显示出更好的定性性能,并与PETVAS和ITAS-2010有更高的相关性。
  • 这些发现提示,使用PETVAS和PTX-3替代SUVmax和CRP/ESR在TAK临床评估中具有潜在优势。

研究设计与样本

  • 研究分析了来自54例TAK患者的64次PET/CT扫描。
  • 炎症活动性由医师整体评估定性确定,并由ITAS-2010评分定量确定。
  • SUVmax和PETVAS通过共识审阅获得,并测量了CRP、ESR和PTX-3水平。
  • 定性诊断性能与定量相关性分别采用ROC曲线和Spearman相关系数进行比较。

主要发现

  • 活动期患者的CRP、ESR、PTX-3、SUVmax、PETVAS及ITAS-2010评分均显著高于非活动期患者。
  • PETVAS与PTX-3的ROC曲线下面积和Youden指数高于SUVmax、CRP、ESR和ITAS-2010。
  • 在所有患者中或活动组内,PETVAS与PTX-3同ITAS-2010的Spearman相关系数高于其他指标。
  • 随访期间PETVAS与PTX-3的变化趋势与临床进展/缓解评估的相关性比其他指标更紧密。

关键数值与推荐

  • 活动性由医师整体评估定性确定,并由ITAS-2010评分定量确定。
  • PETVAS与PTX-3的ROC曲线下面积和Youden指数高于SUVmax、CRP、ESR和ITAS-2010。
  • PETVAS与PTX-3同ITAS-2010的Spearman相关系数高于其他指标。

临床怎么用

  • 作者认为,使用PETVAS和PTX-3替代SUVmax和CRP/ESR在TAK临床评估中具有潜在优势。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To assess the performance of PET vascular activity score (PETVAS) in comparison with SUVmax, inflammatory biomarkers and ITAS-2010 score in a cohort of TAK patients. METHODS: Sixty-four PET/CT scans acquired from 54 TAK patients were analyzed. The inflammatory activity was qualitatively determined by physician's global assessment and quantitatively determined by ITAS-2010 score. SUVmax and PETVAS were acquired by consensus review. Levels of the inflammatory biomarkers C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), and pentraxin-3 (PTX-3) were measured. Performance of the qualitative diagnoses and the quantitative correlation were, respectively, compared by receiver operating characteristic (ROC) curve and Spearman correlation coefficient. RESULTS: The biomarkers (CRP, ESR, PTX-3), PET uptake values (SUVmax, PETVAS), and ITAS-2010 scores were all significantly higher in active patients than in non-active ones. The area under the ROC curve and Youden Index of PETVAS and PTX-3 were higher than those of SUVmax, CRP, ESR, and ITAS-2010. PETVAS and PTX-3 resulted in a higher Spearman correlation coefficient with ITAS-2010 than other criteria, either among all patients or within the active group. Alteration trends of PETVAS and PTX-3 during follow-up showed a tighter correlation with clinical progression/remission assessment than other criteria. CONCLUSIONS: In TAK evaluation, PETVAS is superior for qualitative and quantitative assessment, compared with the regional SUVmax. Compared to CRP and ESR, inflammatory biomarker PTX-3 shows better qualitative performance and a higher correlation with PETVAS and ITAS-2010. These findings indicate that the use of PETVAS and PTX-3, instead of SUVmax and CRP/ESR, has potential advantages in the clinical evaluation of TAK.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Kang F, Han Q, Zhou X, et al. Performance of the PET vascular activity score (PETVAS) for qualitative and quantitative assessment of inflammatory activity in Takayasu's arteritis patients. Eur J Nucl Med Mol Imaging. 2020. PMID: 32567005. doi:10.1007/s00259-020-04871-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。